此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Non-pharmacological Interventions for People With Mild Cognitive Impairment in the Community (CNPI-MCI)

2026年7月11日 更新者:Yiran Yue、Anhui Medical University

Development of a 'Community-Family Mutual Support' Intervention Model for Patients With Mild Cognitive Impairment Based on Social Support Theory

Mild cognitive impairment (MCI) may increase the risk of dementia. This study will evaluate an 8-week community-family mutual support intervention for adults aged 60 years or older with MCI. Participants will be randomly assigned to an intervention group or a control group. The control group will receive routine community care, while the intervention group will additionally receive cognitive training, health education, family support, mutual support activities, and individualized feedback. Cognitive function, daily functioning, emotional status, and social support will be assessed before and after the intervention.

研究概览

研究类型

介入性

注册 (估计的)

70

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Aged 60 years or older.
  • Meets the diagnostic criteria for mild cognitive impairment, including subjective cognitive decline, objective impairment in at least one cognitive domain, relatively preserved activities of daily living, and no diagnosis of dementia.
  • Has lived in the study community for at least 6 months.
  • Has completed primary school or above and is able to read and write.
  • Is able to communicate and complete the study assessments and intervention activities.
  • Voluntarily participates and provides written informed consent.

Exclusion Criteria:

  • Unable to communicate effectively.
  • Has severe visual or hearing impairment that prevents participation.
  • Has dementia, schizophrenia, or another severe psychiatric disorder.
  • Has a serious or unstable physical illness that prevents participation in the intervention.
  • Is currently participating in another cognitive training or similar intervention study.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Community-Family Mutual Support Intervention
Participants will receive routine community care plus an 8-week community-family mutual support intervention based on social support theory. The intervention includes health education, cognitive training, emotional self-monitoring, family involvement, mutual support between participating families, group activities, and individualized feedback.
Participants will receive an 8-week community-family mutual support intervention in addition to routine community care. Guided by social support theory, the program integrates informational, emotional, instrumental, and appraisal support. It includes MCI-related health education, cognitive training, physical activity guidance, emotional self-monitoring, home-based practice with family assistance, mutual support between paired families, group activities, and individualized feedback. The intervention will be delivered through community-based sessions and supported home activities by trained researchers and community nurses.
有源比较器:Routine Community Care
Participants will receive routine community care, including standard health education and usual community-based health services, during the 8-week study period. They will not receive the community-family mutual support intervention.
Participants will receive routine community care, including standard health education and usual community-based health services, during the 8-week study period. They will not receive the community-family mutual support intervention.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Change in Cognitive Function Assessed by the Montreal Cognitive Assessment (MoCA)
大体时间:From enrollment to the end of treatment at 8 weeks
From enrollment to the end of treatment at 8 weeks

次要结果测量

结果测量
措施说明
大体时间
Change From Baseline in Social Support Rating Scale (SSRS) Total Score
大体时间:From enrollment to the end of treatment at 8 weeks
Social support will be assessed using the 10-item Social Support Rating Scale (SSRS). The total score ranges from 12 to 66 points, with higher scores indicating greater social support. The outcome measure is the change in the total score from baseline to Week 8.
From enrollment to the end of treatment at 8 weeks
Change From Baseline in Patient Health Questionnaire-9 (PHQ-9) Total Score
大体时间:From enrollment to the end of treatment at 8 weeks
Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9). Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27. Higher scores indicate more severe depressive symptoms. The outcome measure is the change in the PHQ-9 total score from baseline to Week 8.
From enrollment to the end of treatment at 8 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年7月28日

初级完成 (估计的)

2026年9月28日

研究完成 (估计的)

2026年10月28日

研究注册日期

首次提交

2026年7月7日

首先提交符合 QC 标准的

2026年7月11日

首次发布 (实际的)

2026年7月14日

研究记录更新

最后更新发布 (实际的)

2026年7月14日

上次提交的符合 QC 标准的更新

2026年7月11日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • 81251000 (其他赠款/资助编号:Biomedical Ethics Committee of Anhui Medical University)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅